Phosphagenics debuts Elixia skin care range with TPM technology

The Elixia product range uses patented Targeted Penetration Matrix (TPM) delivery technology fundamental to the company's pharmaceutical products that increases absorption of molecules.

"The technology lends itself perfectly to skin care, and the inclusion of TPM within the Elixia range will increase the absorption of active ingredients used in the cosmetic industry, compared to other marketed topical applications," said Phosphagenics' chief operating officer Dr Esra Ogru.

Based on Vitamin E research

The TPM technology was developed using a Vitamin E phosphate, or alpha-tocopheryl phosphate, (TP) mixture, following research by Phosphogenics that showed TP to have increased activity over standard Vitamin E (alpha-tocopheryl).

TP has been shown to reduce redness, protect against UV induced photo damage, heal and prevent acne and have anti-inflammatory properties, the company said.

According to Phosphagenics, the structure of the tocopheryl phosphates used in the TPM delivery system increases the absorption of the tocopheryl phosphate itself and the delivery and penetration of other molecules formulated with this technology.

"This is the perfect combination of a great skincare line plus scientifically proven biotechnology to deliver ingredients such as anti-ageing retinol deeply into the skin. And our advantage is that we have a whole pharmaceutical company to back up our credentials and reputation," said Dr Ogru.

The Elixia skin care line comprises six products including an anti-oxidant serum and a cream cleanser. Check out the full range here.